Feasibility, face, and content validity of quantitative computed tomography in interstitial lung disease related to connective tissue diseases-Reference-Cited by-同舟云学术

Feasibility, face, and content validity of quantitative computed tomography in interstitial lung disease related to connective tissue diseases

Published:2021-07-19 Issue:0 Volume:0 Page:
ISSN:2191-0286
Container-title:Journal of Basic and Clinical Physiology and Pharmacology
language:en
Short-container-title:

Author:

Sambataro Gianluca¹²,Sambataro Domenico¹²,Orlandi Martina³,Battisti Sofia⁴,Cavagna Lorenzo⁵,Sverzellati Nicola⁶,Silva Mario⁶,Palmucci Stefano⁷,Colaci Michele²,Malatino Lorenzo²,Ariani Alarico⁸

Affiliation:

1. Artroreuma SRL, Outpatient of Rheumatology Accredited with Italian National Health System , Mascalucia , Catania , Italy

2. Department of Clinical and Experimental Medicine , University of Catania , Catania , Italy

3. Department of Experimental and Clinical Medicine , University of Florence , Florence , Italy

4. Department of Radiology , AUSL Romagna “M. Bufalini” Hospital , Cesena , Italy

5. Division of Rheumatology , University and IRCCS “Policlinico San Matteo” Fundation , Pavia , Italy

6. Department of Medicine and Surgery, Section of Radiology , University of Parma , Parma , Italy

7. Department of Medical Surgical Sciences and Advanced Technologies “GF Ingrassia” , University Hospital “Policlinico Vittorio Emanuele”, University of Catania , Catania , Italy

8. Department of Medicine, Internal Medicine and Rheumatology , Azienda Ospedaliero Universitaria di Parma , Parma , Italy

Abstract

Abstract Objectives Quantitative computed tomography (QCT) is a promising tool for objective assessment of interstitial lung disease (ILD) related to connective tissue diseases (CTD). However, its validity was never investigated. The aim of this study was to assess QCT feasibility, face, and content validity evaluation concerning CTD-ILD. Methods A rheumatologist and a chest radiologist conceived an online survey with nine statements: Two about general issue involving CTD-ILD, one for the face validity, three both for content validity and feasibility. Each statement had to be rated with a score from 0 to 100, respectively, (complete disagreement and agreement). We considered a statement supported by the experts if the median score was ≥75.0. Results A panel of 14 experts (11 from Europe, three from America) with a nine years median experience was enrolled. All the statements about feasibility, face and content validity were supported, except for QCT capability to recognize elementary lesions. Conclusions The panel of experts supported feasibility, face, and content validity of QCT assessment concerning CTD-ILD. This may stimulate a greater use in clinical practice and further studies to confirm its discriminative properties and its construct validity.

Publisher

Walter de Gruyter GmbH

Subject

Drug Discovery,Pharmacology,General Medicine,Physiology

Link

https://www.degruyter.com/document/doi/10.1515/jbcpp-2021-0110/pdf

Reference29 articles.

1. American Thoracic Society/European Respiratory Society. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002;165:277–304. https://doi.org/10.1164/ajrccm.165.2.ats01.

2. Duchemann, B, Annesi-Maesano, I, de Naurois, CJ, Sanyal, S, Brillet, PY, Brauner, M, et al.. Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris. Eur Respir J 2017;50:1602419. https://doi.org/10.1183/13993003.02419-2016.

3. Fischer, A, du Bois, R. Interstitial lung disease in connective tissue disorders. Lancet 2012;380:689–98. https://doi.org/10.1016/s0140-6736(12)61079-4.

4. Sambataro, D, Sambataro, G, Pignataro, F, Zanframundo, G, Codullo, V, Fagone, E, et al.. Patients with interstitial lung disease secondary to autoimmune diseases: how to recognize them? Diagnostics 2020;10:208. https://doi.org/10.3390/diagnostics10040208.

5. Bartoloni, E, Gonzalez-Gay, MA, Scirè, C, Castaneda, S, Gerli, R, Lopez-Longo, FJ, et al.. Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: results from a multicenter, international and retrospective study. Autoimmun Rev 2017;16:253–7. https://doi.org/10.1016/j.autrev.2017.01.008.